BAJRAMI, ALBULENA
 Distribuzione geografica
Continente #
NA - Nord America 291
EU - Europa 287
AS - Asia 145
SA - Sud America 6
AF - Africa 3
Totale 732
Nazione #
US - Stati Uniti d'America 289
CN - Cina 88
IT - Italia 73
SG - Singapore 43
GB - Regno Unito 41
IE - Irlanda 31
SE - Svezia 29
RU - Federazione Russa 28
FR - Francia 26
DE - Germania 25
FI - Finlandia 18
ID - Indonesia 4
NL - Olanda 4
UA - Ucraina 4
BE - Belgio 3
TG - Togo 3
BR - Brasile 2
HR - Croazia 2
KR - Corea 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
BD - Bangladesh 1
CA - Canada 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
HK - Hong Kong 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
PA - Panama 1
PT - Portogallo 1
VN - Vietnam 1
Totale 732
Città #
Chandler 86
Southend 38
Singapore 32
Dublin 31
Ashburn 25
Verona 25
Beijing 22
Princeton 16
Jacksonville 15
Helsinki 13
Sant'Ambrogio di Valpolicella 13
Houston 10
Lawrence 9
Wilmington 9
Munich 8
Redmond 8
Jinan 7
Redwood City 7
Riva Del Garda 7
New York 6
Sindelfingen 6
Duncan 5
Lappeenranta 5
Haikou 4
Hebei 4
Jakarta 4
Tianjin 4
Boydton 3
Brussels 3
Chions 3
Dongguan 3
Jiaxing 3
Lomé 3
Nanjing 3
Ningbo 3
Padova 3
Paris 3
Washington 3
Albiate 2
Amsterdam 2
Bonndorf 2
Cambridge 2
Campinas 2
Fairfield 2
Ferrara 2
Guangzhou 2
Lima 2
London 2
Los Angeles 2
Moscow 2
Roverbella 2
San Diego 2
Seattle 2
Seoul 2
Taiyuan 2
Trento 2
Woodbridge 2
Zagreb 2
Zhengzhou 2
Atlanta 1
Bordeaux 1
Boston 1
Brescia 1
Buenos Aires 1
Colombo 1
Corsico 1
Dallas 1
Dhaka 1
Fuzhou 1
Guayaquil 1
Ho Chi Minh City 1
Hong Kong 1
Horben 1
Legnago 1
Nanchang 1
Norwalk 1
Novokuznetsk 1
Prague 1
Quanzhou 1
Radeberg 1
San Francisco 1
Sarnthein 1
Tel Aviv 1
Tirana 1
Toronto 1
Vientiane 1
Yerevan 1
Yiwu 1
Totale 523
Nome #
Microstructural modulations in the hippocampus allow to characterizing relapsing-remitting versus primary progressive multiple sclerosis 124
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity 91
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events 86
Unraveling the MRI-Based Microstructural Signatures Behind Primary Progressive and Relapsing-Remitting Multiple Sclerosis Phenotypes 80
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS 71
The effect of fingolimod on focal and diffuse grey matter damage in active MS patients 67
Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables 65
Diffusion MRI and silver standard masks to improve CNN-based thalamus segmentation 56
Artery of Percheron stroke from carotid lesion 52
Feasibility of detecting atrophy relevant for disability and cognition in multiple sclerosis using 3D-FLAIR 20
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 20
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis 19
Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study 8
Totale 759
Categoria #
all - tutte 3.677
article - articoli 2.873
book - libri 0
conference - conferenze 804
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.354


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202024 0 0 0 0 0 2 2 0 1 1 14 4
2020/202152 3 5 0 5 18 8 4 1 2 1 5 0
2021/2022112 6 35 0 10 2 4 8 10 4 3 8 22
2022/2023248 12 33 24 47 14 41 36 9 22 0 4 6
2023/2024136 7 10 10 10 10 22 13 7 3 14 24 6
2024/2025133 15 10 11 52 16 29 0 0 0 0 0 0
Totale 759